Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved ...

Currently, chemotherapy remains a common treatment for biliary tract cancers, which have a limited survival rate.

Zanidatamab is the first agent approved specifically for advanced, HER2-positive second-line biliary tract cancer.